Matching articles for "Upper respiratory infections"

In Brief: Mucinex

   
The Medical Letter on Drugs and Therapeutics • February 14, 2005;  (Issue 1202)
Patients may be asking health care providers about the safety and effectiveness of Mucinex (Adams), which is being heavily advertised on television and elsewhere for treatment of respiratory congestion. These...
Patients may be asking health care providers about the safety and effectiveness of Mucinex (Adams), which is being heavily advertised on television and elsewhere for treatment of respiratory congestion. These ads suggest that Mucinex is a new drug, when actually it is an extended-release formulation of guaifenesin, an old expectorant. Guaifenesin increases the volume of secretions in the respiratory tract, which facilitates removal of viscous mucus by coughing. Medical Letter consultants have not been impressed by its effectiveness. Guaifenesin is in the category of drugs - Generally Recognized as Safe - (GRAS) and is included in many prescription and over-the-counter cough remedies,1 but the manufacturer of Mucinex nevertheless sought and received FDA approval. Now the FDA has removed all single-ingredient extended-release guaifenesin products from the market until the manufacturers also apply for and receive approval. Mucinex is available without a prescription for patients 12 years or older and is taken every 12 hours. A bottle of 20 600-mg tablets costs about $12 at a local chain pharmacy.

1. Over-the-counter (OTC) cough remedies. Med Lett Drugs Ther 2001; 43:23.
Med Lett Drugs Ther. 2005 Feb 14;47(1202):16 | Show Full IntroductionHide Full Introduction

Echinacea for Prevention and Treatment of Upper Respiratory Infections

   
The Medical Letter on Drugs and Therapeutics • April 1, 2002;  (Issue 1127)
Echinacea, a plant also called purple coneflower, is widely used as a dietary supplement for prevention and treatment of...
Echinacea, a plant also called purple coneflower, is widely used as a dietary supplement for prevention and treatment of colds.
Med Lett Drugs Ther. 2002 Apr 1;44(1127):29-30 | Show Full IntroductionHide Full Introduction